CLL Updates and the Venetoclax Story With Matt Davids
Healthcare Unfiltered
Exploring Drug Mechanisms in Cancer Treatment
This chapter explores the mechanisms of covalent and non-covalent degraders used in cancer therapies, focusing on their role in targeted proteasomal destruction of resistance-associated proteins. It also discusses the potential advantages of combining these drug classes to improve treatment outcomes.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
